𝔖 Bobbio Scriptorium

✦ LIBER ✦

A novel hidradenitis suppurativa efficacy variable, HiSCR (hidradenitis suppurativa clinical response), is responsive to change with adalimumab therapy: Results of a phase II study

Book ID: 122678277
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 50 KB
Volume: 68
Category: Article
ISSN: 1097-6787
DOI: 10.1016/j.jaad.2012.12.170

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy Results Using a Novel Hidradeni

Efficacy Results Using a Novel Hidradenitis Suppurativa Endpoint, Hiscr (Hidradenitis Suppurativa Clinical Response), From The Placebo-Controlled Phase of a Phase 2 Adalimumab Study

✍ Scheinfeld, N.S.; Sobell, J.M.; Gu, Y.; Sood, S. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Efficacy results using a novel hidradeni

Efficacy results using a novel hidradenitis suppurativa endpoint, HiSCR (hidradenitis suppurativa clinical response), from the placebo-controlled phase of a phase 2 adalimumab study

📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Efficacy and safety of adalimumab for mo

Efficacy and safety of adalimumab for moderate to severe hidradenitis suppurativa: Results from the open-label phase of a 52-week phase II, randomized, study

📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Efficacy and safety of adalimumab in tre

Efficacy and safety of adalimumab in treatment of moderate to severe hidradenitis suppurativa: Results from the placebo-controlled portion of a phase II, randomized, double-blind study

📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Efficacy and safety of adalimumab treatm

Efficacy and safety of adalimumab treatment in women with moderate to severe hidradenitis suppurativa: Analysis from the placebo-controlled portion of a phase II, randomized, double-blind study

📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 49 KB

O282 EFFICACY AND SAFETY OF ADALIMUMAB T

O282 EFFICACY AND SAFETY OF ADALIMUMAB TREATMENT IN WOMEN WITH MODERATE TO SEVERE HIDRADENITIS SUPPURATIVA: ANALYSIS FROM THE PLACEBO-CONTROLLED PORTION OF A PHASE II, RANDOMIZED, DOUBLE-BLIND STUDY

✍ Gottlieb, A.B.; Menter, A.; Belknap, K.; Chen, K.; Teixeira, H.D. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 58 KB